Serum gamma-glutamyltransferase levels predict clinical outcomes in hemodialysis patients

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Park, Woo Yeong ^a   Koh, Eun Sil ^a   Kim, Su Hyun ^b   Kim, Young Ok ^a   Jin, Dong Chan ^a   Song, Ho Chul ^a   Choi, Euy Jin ^a   Kim, Yong Lim ^c   Kim, Yon Su ^d   Kang, Shin Wook ^e   Kim, Nam Ho ^f   Yang, Chul Woo ^a   Kim, Yong Kyun ^a  

^a The Catholic University of Korea   (South Korea)

^b Chung Ang University   (South Korea)

^c Kyungpook National University   (South Korea)

^d Seoul National University   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

^f Chonnam National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLESTEROL; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; HEPATITIS B ANTIGEN; HEPATITIS C ANTIBODY; PARATHYROID HORMONE; PHOSPHORUS; TRIACYLGLYCEROL; URIC ACID; BIOLOGICAL MARKER; GAMMA-GLUTAMYLTRANSFERASE, HUMAN;

ADULT; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTEREMIA; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEVICE INFECTION; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE REGISTRY; END STAGE RENAL DISEASE; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTROINTESTINAL INFECTION; HAZARD RATIO; HEART ARRHYTHMIA; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INFECTION; ISCHEMIC HEART DISEASE; KOREA; LIVER DISEASE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCULOSKELETAL DISEASE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PHOSPHATE BLOOD LEVEL; PREDICTION; PREVALENCE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RESPIRATORY TRACT INFECTION; RISK FACTOR; SEX RATIO; SOFT TISSUE INFECTION; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; UNIVARIATE ANALYSIS; URINARY TRACT INFECTION; VASCULAR ACCESS RELATED INFECTION; ADVERSE EFFECTS; BLOOD; CARDIOVASCULAR DISEASES; ENZYMOLOGY; HEMODIALYSIS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PROGNOSIS; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE;

BIOMARKERS; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HOSPITALIZATION; HUMANS; INFECTION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; SURVIVAL RATE;

EID: 84945943228     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138159     Document Type: Article

References (32)

1. Locatelli F, Marcelli D, Conte F, D'Amico M, Del Vecchio L, Limido A, et al. Cardiovascular disease in chronic renal failure: The challenge continues. Registro Lombardo Dialisi e Trapianto. Nephrol Dial Transplant. 2000; 15 Suppl 5: 69-80. PMID: 11073278
2. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: An emerging threat to patient outcome. Nephrology Dialysis Transplantation. 2003; 18: 1272-80.
3. Handelman GJ. Evaluation of Oxidant Stress in Dialysis Patients. Blood Purif. 2000; 18: 343-9. PMID: 10965079
4. Dominici S, Paolicchi A, Corti A, Maellaro E, Pompella A. Prooxidant reactions promoted by soluble and cell-bound gamma-glutamyltransferase activity. Methods Enzymol. 2005; 401: 484-501. PMID: 16399404
5. Jiang S, Jiang D, Tao Y. Role of gamma-glutamyltransferase in cardiovascular diseases. Exp Clin Cardiol. 2013; 18: 53-6. PMID: 24294039
6. Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res. 2004; 38: 535-9. PMID: 15346644
7. Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: Triggering oxidative stress within the plaque. Circulation. 2005; 112: 2078-80. PMID: 16203922
8. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: An epidemiological investigation in a cohort of 163, 944 Austrian adults. Circulation. 2005; 112: 2130-7. PMID: 16186419
9. Breitling LP, Claessen H, Drath C, Arndt V, Brenner H. Gamma-glutamyltransferase, general and cause-specific mortality in 19, 000 construction workers followed over 20 years. J Hepatol. 2011; 55: 594-601. doi: 10.1016/j.jhep.2010.12.029 PMID: 21256904
10. Sluik D, Beulens JW, Weikert C, van Dieren S, Spijkerman AM, van der AD, et al. Gamma-glutamyltransferase, cardiovascular disease and mortality in individuals with diabetes mellitus. Diabetes Metab Res Rev. 2012; 28: 284-8. doi: 10.1002/dmrr.2261 PMID: 22144398
11. Del Vecchio L, Locatelli F, Carini M. What we know about oxidative stress in patients with chronic kidney disease on dialysis-clinical effects, potential treatment, and prevention. Semin Dial. 2011; 24: 56-64. doi: 10.1111/j.1525-139X.2010.00819.x PMID: 21299632
12. Franzini M, Fornaciari I, Vico T, Moncini M, Cellesi V, Meini M, et al. High-sensitivity gamma-glutamyltransferase fraction pattern in alcohol addicts and abstainers. Drug Alcohol Depend. 2013; 127: 239-42. doi: 10.1016/j.drugalcdep.2012.06.004 PMID: 22749559
13. Tetta C, Biasioli S, Schiavon R, Inguaggiato P, David S, Panichi V, et al. An overview of haemodialysis and oxidant stress. Blood Purif. 1999; 17: 118-26. PMID: 10449869
14. Canaud B, Cristol J, Morena M, Leray-Moragues H, Bosc J, Vaussenat F. Imbalance of oxidants and antioxidants in haemodialysis patients. Blood Purif. 1999; 17: 99-106. PMID: 10449867
15. Postorino M, Marino C, Tripepi G, Zoccali C. Gammaglutamyltransferase in ESRD as a predictor of allcause and cardiovascular mortality: Another facet of oxidative stress burden. Kidney Int Suppl. 2008: S64-6. doi: 10.1038/ki.2008.515 PMID: 19034330
16. Van Hemelrijck M, Eichholzer M, Faeh D, Rohrmann S. Ability of a biomarker-based score to predict death from circulatory disease and cancer in NHANES III. BMC Public Health. 2012; 12: 895. doi: 10. 1186/1471-2458-12-895 PMID: 23092358
17. Van Hemelrijck M, Jassem W, Walldius G, Fentiman IS, Hammar N, Lambe M, et al. Gamma-glutamyltransferase and risk of cancer in a cohort of 545, 460 persons-The Swedish AMORIS study. Eur J Cancer. 2011; 47: 2033-41. doi: 10.1016/j.ejca.2011.03.010 PMID: 21486691
18. Strasak AM, Pfeiffer RM, Klenk J, Hilbe W, Oberaigner W, Gregory M, et al. Prospective study of the association of gamma-glutamyltransferase with cancer incidence in women. Int J Cancer. 2008; 123: 1902-6. doi: 10.1002/ijc.23714 PMID: 18688855
19. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocr Rev. 2002; 23: 599-622. PMID: 12372842
20. Petta S, Macaluso FS, Barcellona MR, Camma C, Cabibi D, Di Marco V, et al. Serum gamma-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases. PLoS One. 2012; 7: E51165. doi: 10.1371/journal.pone.0051165 PMID: 23227248
21. Ruhl CE, Everhart JE. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology. 2009; 136: 477-85.e11. doi: 10.1053/j. gastro.2008.10.052 PMID: 19100265
22. Long Y, Zeng F, Shi J, Tian H, Chen T. Gamma-glutamyltransferase predicts increased risk of mortality: A systematic review and meta-analysis of prospective observational studies. Free Radic Res. 2014; 48: 716-28. doi: 10.3109/10715762.2014.902055 PMID: 24684379
23. Pohanka M. Role of oxidative stress in infectious diseases. A review. Folia Microbiol (Praha). 2013; 58: 503-13.
24. Nakayama E, Akiba T, Marumo F, Sato C. Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol. 2000; 11: 1896-902. PMID: 11004221
25. Yun KE, Shin CY, Yoon YS, Park HS. Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans. Atherosclerosis. 2009; 205: 533-7. doi: 10.1016/j. atherosclerosis.2008.12.012 PMID: 19159884
26. Harel Z, Wald R, McArthur E, Chertow GM, Harel S, Gruneir A, et al. Rehospitalizations and Emergency Department Visits after Hospital Discharge in Patients Receiving Maintenance Hemodialysis. J Am Soc Nephrol. Epub 2015/04/08. doi: 10.1681/asn.2014060614
27. Dalrymple LS, Mu Y, Romano PS, Nguyen DV, Chertow GM, Delgado C, et al. Outcomes of Infection-Related Hospitalization in Medicare Beneficiaries Receiving In-Center Hemodialysis. Am J Kidney Dis. 2015; 65: 754-62. doi: 10.1053/j.ajkd.2014.11.030 PMID: 25641061
28. Hann HW, Wan S, Myers RE, Hann RS, Xing J, Chen B, et al. Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients. PLoS One. 2012; 7: E47687. doi: 10.1371/journal.pone.0047687 PMID: 23112834
29. Huang CF, Yeh ML, Tsai PC, Hsieh MH, Yang HL, Hsieh MY, et al. Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication. J Hepatol. 2014; 61: 67-74. doi: 10.1016/j.jhep.2014.02.022 PMID: 24613362
30. Youden WJ. Index for rating diagnostic tests. Cancer. 1950; 3: 32-5. PMID: 15405679
31. Sette LH, Almeida Lopes EP. Liver enzymes serum levels in patients with chronic kidney disease on hemodialysis: A comprehensive review. Clinics (Sao Paulo). 2014; 69: 271-8.
32. Alatalo P, Koivisto H, Puukka K, Hietala J, Anttila P, Bloigu R, et al. Biomarkers of liver status in heavy drinkers, moderate drinkers and abstainers. Alcohol Alcohol. 2009; 44: 199-203. doi: 10.1093/alcalc/agn099 PMID: 19054785